semaglutide band Tirzepatide $125 & $99/mo, Compounded GLP-1 (Annual) Semaglutide (Ozempic® & Wegovy®) Before

doi:10.31080/asne.2024.07.0731 Al-Massadi O, Fern J, Diguez C, Nogueiras R, Quiones M

Semaglutide significantly reduces the intensity and frequency of sugar cravings for most patients, but complete elimination varies individually

Semaglutide: Single-Receptor Approach Semaglutide activates the GLP-1 receptor, producing the following effects: Appetite suppression through direct action on hypothalamic neurons that control hunger signaling Delayed gastric emptying that promotes prolonged feelings of fullness after meals Enhanced glucose-dependent insulin secretion from pancreatic beta cells Reduced glucagon secretion (different from glucagon receptor activation) that lowers hepatic glucose output Potential neuroprotective effects currently being studied in Alzheimers disease trials Research by Blundell et al

When a provider initiates an ePA (either through an EHR or a pharmacy portal), the system generates a PAInitiationRequest message: an XML payload defined by NCPDP containing structured fields for patient name, insurance ID, drug code, dosing, diagnosis codes, etc

Clinical trials indicate 15-25% average body weight reduction over 6-12 months, depending on the medication (e.g., more with tirzepatide) and factors like starting weight, lifestyle, and eating habits